Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX

Human Pathology

Volumn 38, Issue 4, 2007, Pages 629-638

  Korkolopoulou, Penelope ^a   Perdiki, Marina ^a   Thymara, Irini ^a   Boviatsis, Efstathios ^a   Agrogiannis, George ^a   Kotsiakis, Xenophon ^a   Angelidakis, Dimitrios ^a   Rologis, Dimitrios ^a   Diamantopoulou, Kalliopi ^b   Thomas Tsagli, Euphemia ^b   Kaklamanis, Loukas ^a   Gatter, Kevin ^c   Patsouris, Efstratios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Asklepeion Voula Hospital   (Greece)

^c Clinical Laboratory Sciences   (United Kingdom)

Author keywords

Astrocytoma; CAIX; HIF 1 ; Hypoxia; VEGF

Indexed keywords

CARBONATE DEHYDRATASE IX; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KI 67 ANTIGEN; THROMBOPLASTIN; VASCULOTROPIN;

ACIDIFICATION; ADULT; AGED; ARTICLE; ASTROCYTE; ASTROCYTOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLIOMA CELL; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MORPHOLOGY; MULTIVARIATE ANALYSIS; NECROSIS; PROTEIN EXPRESSION; SURVIVAL; TUMOR RESISTANCE; UNIVARIATE ANALYSIS; UPREGULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; ASTROCYTOMA; CARBONIC ANHYDRASES; COHORT STUDIES; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33947108844     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.07.020     Document Type: Article

References (44)

1. Dang C.V., and Semenza G.L. Oncogenic alterations of metabolism. Trends Biochem Sci 24 (1999) 68-72
2. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 3 (1997) 177-182
3. Dor Y., and Keshet E. Oxygen and tumour angiogenesis. In: Rubanyi G.M. (Ed). Angiogenesis in health and disease (2000), Marcel Dekker Inc, New York 245-260
4. Blancher C., and Harris A.L. The molecular basis of the hypoxia response pathway: tumour hypoxia as a therapy target. Cancer Metastasis Rev 17 (1998) 187-194
5. Rafstad E.K. Microenvironment-induced cancer metastasis. Int J Radiat Biol 76 (2000) 589-605
6. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15 (1999) 551-578
7. Liu Y., Cox S.R., Morita T., and Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells: identification of a 5′ enhancer. Circ Res 77 (1995) 638-643
8. Pantuck A.J., Zeng G., Belldegrun A.S., and Figlin R.A. Pathobiology, prognosis and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway. Clin Cancer Res 9 (2003) 4641-4652
9. Lindskog S. Structure and mechanism of carbonic anhydrase. Pharmacol Ther 74 (1997) 1-20
10. Yamagata M., Hasuda K., Stamato T., and Tannock I.F. The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase. Br J Cancer 77 (1998) 1726-1731
11. Pastorek J., Pastorekova S., Callebaut I., et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 9 (1994) 2877-2888
12. Potter C., and Harris A.L. Hypoxia-inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target. Cell Cycle 3 (2004) 164-167
13. Korkolopoulou P., Patsouris E., Konstantinidou A.-E., et al. Hypoxia-inducible factor 1α/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis. Neuropathol Appl Neurobiol 30 (2004) 267-278
14. Cavenee W.K., Furnari F.B., Nagane M., et al. Diffusely infiltrating astrocytomas. In: Kleihues P., and Cavenee W.K. (Eds). Pathology and genetics of tumours of the nervous system (2000), IARC Press, Lyon 10-21
15. Wykoff C.C., Beasley N.J.P., Watson P.H., et al. Hypoxia inducible regulation of tumor associated carbonic anhydrases. Cancer Res 60 (2001) 7075-7083
16. Korkolopoulou P., Patsouris E., Kavantzas N., et al. Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms. Neuropathol Appl Neurobiol 28 (2002) 57-66
17. Giatromanolaki A., and Harris A.L. Tumour hypoxia, hypoxia signalling pathways and hypoxia inducible factor expression in human cancer. Anticancer Res 21 (2001) 4317-4324
18. Coleman C.N., Mitchell J.B., and Camphausen K. Tumor hypoxia: chicken, egg or a piece of the farm?. J Clin Oncol 20 (2002) 610-615
19. Hedley D., Pintilie M., Woo J., et al. Carbonic anhydrase IX expression, hypoxia and prognosis in patients with uterine cervical carcinomas. Clin Cancer Res 9 (2003) 5666-5674
20. Wykoff C.C., Beasley N., Watson P.H., et al. Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am J Pathol 158 (2001) 1011-1019
21. Chia S.K., Wykoff C.C., Watson P.H., et al. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 19 (2001) 3660-3668
22. Hoskin P.J., Sibtain A., Daley F.M., and Wilson G.D. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. Br J Cancer 89 (2003) 1290-1297
23. Saarnio J., Parkkila S., Parkkila A.K., et al. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CAIX, with potential value as a marker of cell proliferation. Am J Pathol 153 (1998) 279-285
24. Giatromanolaki A., Koukourakis M.I., Sivridis E., et al. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res 61 (2001) 7992-7998
25. Swinson D.E.B., Jones J.L., Richardson D., et al. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J Clin Oncol 21 (2003) 473-482
26. Beasley N.J.P., Wykoff C.C., Watson P.H., et al. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis and microvessel density. Cancer Res 61 (2001) 5262-5267
27. Hui E.P., Chan A.T.C., Pezzella F., et al. Coexpression of hypoxia-inducible factors 1α and 2α, carbonic anhydrase IX and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clin Cancer Res 8 (2002) 2595-2604
28. Kim S.J., Rabbani Z.N., Vollmer R.T., et al. Carbonic anhydrase IX in early-stage non-small cell lung cancer. Clin Cancer Res 10 (2004) 7925-7933
29. Haapasalo J.A., Nordfors K.M., Hilro M., et al. Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis. Clin Cancer Res 12 (2006) 473-477
30. Birner P., Preusser M., Gelpi E., et al. Expression of hypoxia-related tissue factors correlates with diminished survival of adjuvantly treated patients with chromosome 1p aberrant oligodendroglial neoplasms and therapeutic implications. Clin Cancer Res 10 (2004) 6567-6571
31. Ivanov S.V., Kuzmin I., Wei M.H., et al. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von-Hippel Lindau transgenes. Proc Natl Acad Sci U S A 95 (1998) 12596-12601
32. Forsythe J.A., Jiang B.-H., Iyer N.V., Agani F., Leung S.W., and Koos R.D. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16 (1996) 4604-4613
33. Ivanov S., Liao S.Y., Ivanova A., et al. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 158 (2001) 905-919
34. Kaanders J.H., Wijffels K.I., Marres H.A., et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res 62 (2002) 7066-7074
35. Zhong H., Chiles K., Feldser D., et al. Modulation of hypoxia-inducible factor 1 alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP/pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 60 (2000) 1541-1545
36. Opavsky R., Pastorekova S., Zelnik V., et al. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics 33 (1996) 480-487
37. Shi Q., Abbruzzese J.L., Huang S., Fidler I.J., Xion Q., and Xie K. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin Cancer Res 5 (1999) 3711-3721
38. Shaheen R.M., Tseng W.W., Vellagas R., et al. Effects of an antibody to vascular endothelial growth factor receptor-2 on survival, tumour vascularity and apoptosis in a murine model of colon carcinomatosis. Int J Oncol 18 (2001) 221-226
39. Secomb T.W., Hsu R., Ong E.T., Gross J.F., and Dewhirst M.W. Analysis of the effects of oxygen supply and demand on hypoxic fraction of tumors. Acta Oncol 34 (1995) 313-316
40. Nemoto S., Takeda K., Yu Z.X., Ferrans V.J., and Finkel T. Role for mitochondrial oxidants as regulators of cellular metabolism. Mol Cell Biol 20 (2000) 7311-7318
41. Fischer B., Muller B., Fischer K.G., Baur N., and Kreutz W. Acidic pH inhibits non-MHC-restricted killer cell functions. Clin Immunol 96 (2000) 252-263
42. Robertson N., Potter C., and Harris A.L. Role of carbonic anhydrase IX in human tumor cell growth, survival and invasion. Cancer Res 64 (2004) 6160-6165
43. Höckel M., Schlenger K., Aral B., Mitze M., Schaffer U., and Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56 (1996) 4509-4515
44. Leon S.P., Folkerth R.D., and Black P.M. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77 (1996) 362-372